Capital Investment Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Capital Investment Advisors's ELV Position: Q1 2026 in Review
Capital Investment Advisors reduced its Elevance Health (ELV) stake by 3.4% in Q1 2026, selling an estimated $13.1K and leaving 1,154 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #583.
Capital Investment Advisors first reported a position in ELV in Q4 2018 and has held it in 20 quarters since. The position peaked at $505K in Q2 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Capital Investment Advisors held 1,154 shares of Elevance Health worth $338K as of Q1 2026.
- Capital Investment Advisors sold 40 Elevance Health shares in Q1 2026, an estimated $13.1K.
- Elevance Health made up ﹤0.01% of Capital Investment Advisors's portfolio in Q1 2026, its #583 holding.
- Capital Investment Advisors first reported a position in Elevance Health in Q4 2018 and has held it in 20 quarters since.
- Capital Investment Advisors's Elevance Health position peaked at $505K in Q2 2023.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.